Clinuvel Pharmaceuticals | CUV - Ordinary Share Capital

Stock Price
8.97
Daily Change
-0.07 -0.77%
Monthly
-8.28%
Yearly
-17.02%
Q2 Forecast
8.87

Clinuvel Pharmaceuticals reported AUD50.2M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Medical Developments International AUD 112.66M 2.35M Dec/2025
Mesoblast USD 1.29B 8.58M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025